KMI Q1 2026 Earnings Strong EPS Beat Amid Market Headwinds Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues WD Q1 2026 Earnings EPS Surges Past Estimates with 62 Surprise NAUT Q1 2026 Earnings Narrowed Losses Beat Estimates Amid Platform Progress AGNCP Q1 2026 Earnings Preferred Shares Benefit as EPS Exceeds Estimates by 145 OXLC Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short